EKO International Corp. (EKNL)
EKO International Corp. operates in the Conglomerates industry of the Industrials sector, headquartered in Burlington, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $6,337. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of 7.94 implies it has historically moved more than the broad market.
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.
EKO International Corp. is most often compared with the following Industrials names: